RSS 1.0Presentations (Missouri Regional Life Sciences Summit 2010)
This collection contains the presentations made during the Missouri Regional Life Sciences Summit 2010. Please enter text in the search box above or click on one of the browse options to explore this collection.
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
Recent Submissions
-
Integrating academic research, clinical research and private practice: a unique opportunity for translational medicine
(2010-03)Degeneration or acute damage of nerve cells in the retina due to age-related macular degeneration (AMD), diabetic retinopathy and glaucoma are the major causes of visual loss and blindness in the United States and worldwide. ... -
The “Male Pill”: The Learning Curve from Basic Science to the Drug Development Pipeline and the Strength of Interdisciplinary Collaboration
(2010-03)Nearly five decades have elapsed since the development of the female contraceptive hormone pill. During this time numerous alternative female contraceptive methods have also gained acceptance, however “the pill” and other ... -
In silico Compound Screening for Drug Discovery in the “Cloud”
(2010-03)The need to identify new small molecules and novel binding partners for known bioactive sites remains a constant in drug development. We are aiding VaSSA Informatics in creating informatics methods used to identify ... -
Organ printing: a novel tissue engineering paradigm
(2010)Engineering new tissues, ideally from the patient's own body cells to prevent rejection by the immune system, is a rapidly growing field that rests on three pillars: cells, supporting structures (or scaffold) and stimulating ... -
Commercialization of novel biomarkers of male fertility in humans and farm animals
(2010-03)Each year, US infertility clinics treat 135,000 couples who fail to conceive naturally. Up to 40% of these infertility cases can be attributed to male infertility stemming from poor sperm quality. An additional 20% of ... -
Research in motion
(2010-03)Orthopaedic disorders of the major joints, specifically, osteoarthritis of the hip and knee joints have an enormous economic and functional impact on our society, affecting millions of patients every day. In the late 1960s ... -
Biomedical Tissue Engineering - Where We Go in the Future
(2010-03)Researchers and entrepreneurs examine breakthroughs in tissue engineering and regeneration that enhance healing, remodeling, and recovery. -
Jump Starting and Moving New Technologies to Marketplace
(2010-03)The highway from research in the laboratory to market success has many detours and on/off ramps that are at best confusing to inventors and the populace. Success from technology-based economic development is the outcome ... -
Plants are just very slow animals
(2010-03)Most of us regard plants as quite different from animals, and many of us think of them as furniture. But plants actually share a very large number of biological functions with the animal kingdom, including mechanisms for ... -
Navigating the two-way street of comparative oncology
(2010)Companion animals offer a unique model for study of spontaneously occurring cancer for many reasons. Our pets share our environment, thus may have similar exposure to environmental carcinogens. The technology for diagnosis ... -
Patent litigation issues
(2010-03)Joe Mahoney addressed issues of patent law and patent infringement, citing several examples from the pharmaceutical industry. -
Translating novel drug delivery techniques to ophthalmic products-unique opportunity for collaboration between academia and pharmaceutical industry
(2010-03)To improve human health, scientific discoveries must be translated into clinical applications. Such discoveries typically begin at "the bench" with basic research — in which scientists study disease at a molecular or ... -
KU Center for Technology Commercialization: "promoting innovation to benefit society"
(2010-03)The presentation will examine the challenges of the university technology transfer office in assessing new invention disclosures and the various means of doing so. The presentation will also provide information on different ... -
Shor-Line: we are an industry leader
(2010-03)Shor-Line has been a part of the animal health industry since the company's founding in 1927. In the early years, Shor-Line's involvement related mainly to large animal applications. Back then the local vet took care of ... -
Genetically-modified animals: powerful tools for biomedical research
(2010)The University of Missouri houses three National Institutes of Health (NIH), National Center for Research Resources (NCRR) animal resource centers. These animal resource centers are: (1) the Mutant Mouse Regional Resource ... -
Interactive mapping: overlaying local and national data
(2010-03)The Center for Applied Research and Environmental Systems (CARES) at the University of Missouri-Columbia has a long history of integrating Internet accessibility with emerging technologies to assist underserved, under-resourced, ... -
Understanding the Risk for Neuropsychiatric Disorders Using Functional Brain Imaging
(2010)MU has recently opened the Brain Imaging Center, a research dedicated Magnetic Resonance Imaging (MRI) facility. Research at the center is focused on understanding the nature of basic cognitive and emotional processes as ... -
One health: a guiding imperative
(2010)Given the large proportion of households that include pets, this is perhaps a most important time to consider human-companion animal interaction as a vehicle to facilitate One Health (human-animal health). The potential ... -
Neuro-modulation techniques in humans
(University of Missouri--Columbia, 2010)During the past two decades noninvasive brain stimulation techniques such as transcranial direct current stimulation and transcranial magnetic stimulation are being increasingly used for the diagnosis and treatment of ... -
Life Sciences Patent Prosecution Pitfalls
(2010-03)Robert Hanson discussed the application of patent requirements to biotechnology and life science inventions.